Oncothyreon HomeContactSite MapGlossary
Investors
 
Stock Information
NASDAQ: ONTY
$7.91   + 0.24
Feb 3, 2012
4:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
Stock Information
Analyst Coverage

Firm Analyst
Cowen and Company   Simos Simeonidis, Ph.D.
Cantor Fitzgerald   Mara Goldstein
Cross Current Research, LLC   Alex To
JMP Securities   Charles Duncan
Rodman & Renshaw   Reni Benjamin, Ph.D
WedBush Securities   Greg Wade, Ph.D

Oncothyreon is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Oncothyreon's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Oncothyreon or its management. Oncothyreon does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

return to top ^

About Oncothyreon | Pipeline | Clinical Trials | Business Development | Investors | News & Events